Behind Every Order, There’s a Team That Cares Pharmaceutical distribution may be complex, but our mission is simple: make our clients’ lives easier. Whether it’s tracking down a hard-to-find medication or ensuring timely delivery to a busy facility, our customer service team goes above and beyond to make sure clients feel supported every step of […]
The New Face of Pharma Logistics For years, the pharmaceutical supply chain was something few outside the industry thought about. Products shipped, arrived, and stocked. Simple enough, right? But in 2025, the supply chain is undergoing a major transformation, and it’s anything but business as usual. Pharmaceutical distributors are now investing in smart logistics systems,
Why The Pharmaceutical Supply Chain Is Getting a Makeover Read More »
Last month brought pivotal FDA decisions that could shape the future of care in endocrinology and oncology. Two highly anticipated reviews—the approval of Crinetics Pharmaceuticals’ new oral treatment for acromegaly and the FDA’s decision on Merck’s subcutaneous formulation of Keytruda—captured the industry’s attention. Crinetics Pharmaceuticals: Oral Acromegaly Treatment On September 25, the FDA announced its
September FDA Decisions: Key Updates in Acromegaly and Cancer Treatments Read More »
At Atlantic Biologicals, our mission has always been clear: provide healthcare providers with the highest quality pharmaceutical products while ensuring safety, compliance, and efficiency at every step. One of the ways we uphold this standard is through unit dose repackaging. Why Repackaging Matters Repackaging plays a critical role in today’s healthcare environment. By transforming medications
Unit Dose Repackaging: How We Deliver Safe, Reliable Solutions Read More »
One of the most significant trends shaping the market today is the rise of mergers and acquisitions (M&A). Large companies in the pharmaceutical industry have been acquiring smaller biotech firms. In result, expanding their pipelines and investing in groundbreaking therapies. How Mergers and Acquisitions Drive Innovation Companies like Novartis are demonstrating a strong interest in
The Impact of Mergers and Acquisitions on the Pharmaceutical Industry Read More »
Hospitals and pharmacies must navigate complex regulations while ensuring patient safety. One critical aspect of pharmaceutical management is the handling of potentially hazardous medications. At Atlantic Biologicals, we understand the importance of providing healthcare facilities with safe and compliant solutions for these high-risk medications. Why These Medications Require Specialized Handling Hazardous medications, as classified by
Atlantic Biologicals: Providing Safe and Compliant Hazardous Medication Read More »
The pharmaceutical industry is undergoing a transformative shift, with artificial intelligence (AI) and big data analytics playing a crucial role in accelerating medication discovery and development. Companies are leveraging these cutting-edge technologies to streamline research, improve efficiency, and enhance patient outcomes. As the demand for faster and more cost-effective medication development grows, AI-driven approaches are
AI and Data Analytics: Transforming Pharmaceutical Innovation Read More »
The FDA recently approved Vertex Pharmaceuticals’ groundbreaking non-opioid pain medication, Journavx. This approval represents a major milestone in pain management. It offers patients an alternative to opioid-based treatments while addressing concerns about addiction and dependency. The decision comes at a critical time when the healthcare industry is actively seeking safer and more effective pain relief
Pharmapack 2025, one of the most anticipated events in the pharmaceutical and healthcare industries, is set to take place in Paris, France. Scheduled for this month, this global gathering will bring together key players from pharmaceutical packaging, medication delivery, medical devices, and machinery sectors. The event promises to spotlight cutting-edge innovations and foster meaningful collaborations
Pharmapack 2025: A Hub for Innovation in Pharmaceutical Packaging and Delivery Read More »
When you think about the NFL Draft, images of scouts, strategy, and high-stakes decisions come to mind. Big Pharma, on the other hand, conjures up thoughts of clinical trials, research breakthroughs, and regulatory hurdles. At first glance, these two industries might seem worlds apart. However, for investors, the parallels between the NFL Draft and Big
What the NFL Draft Can Teach Investors About Big Pharma Read More »